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Arthritogenic alphaviruses, including Ross River virus (RRV) and chikungunya virus, are mosquito-borne
viruses that cause significant human disease worldwide, including explosive epidemics that can result in
thousands to millions of infected individuals. Similar to infection of humans, infection of C57BL/6 mice with
RRV results in severe monocytic inflammation of bone, joint, and skeletal muscle tissues. We demonstrate here
that the complement system, an important component of the innate immune response, enhances the severity
of RRV-induced disease in mice. Complement activation products were detected in the inflamed tissues and in
the serum of RRV-infected wild-type mice. Furthermore, mice deficient in C3 (C3/), the central component
of the complement system, developed much less severe disease signs than did wild-type mice. Complement-
mediated chemotaxis is essential for many inflammatory arthritides; however, RRV-infected wild-type and
C3/ mice had similar numbers and composition of inflammatory infiltrates within hind limb skeletal muscle
tissue. Despite similar inflammatory infiltrates, RRV-infected C3/ mice exhibited far less severe destruction
of skeletal muscle tissue. In addition to these studies, complement activation was also detected in synovial fluid
from RRV-infected patients. Taken together, these findings indicate that complement activation occurs in the
tissues of humans and mice infected with RRV and suggest that complement plays an essential role in the
effector phase, but not the inductive phase, of RRV-induced arthritis and myositis.
Infection of humans with arthritogenic alphaviruses, such as
Ross River virus (RRV), chikungunya virus, o’nyong-nyong
virus, mayaro virus, and others, is a global cause of debilitating
musculoskeletal disease (12, 37). These viruses are also of
serious concern due to their ability to cause explosive epidem-
ics that can involve thousands to millions of patients and po-
tentially lead to emergence in new geographic regions. This has
been highlighted by the recent epidemic reemergence of
chikungunya virus in the southeastern islands of the Indian
Ocean, as well as India. Since January 2005, an estimated
244,000 individuals have been infected on Réunion island
alone, as well as thousands of additional cases on other islands,
including Comoros, Mayotte, Seychelles, and Mauritius (34).
Since many of these islands are popular tourist destinations,
chikungunya virus-infected individuals returning from these
areas have been identified in France, Germany, Canada, and
other regions where the virus is not endemic. In addition, past
epidemics include an epidemic in 1979 and 1980 of RRV
disease in the South Pacific that involved more than 60,000
patients (14) and an epidemic from 1959 to 1962 of o’nyong-
nyong fever in Africa that involved at least 2 million patients
(41).
Humans infected with RRV, as well as other arthritogenic
alphaviruses, experience disease symptoms that include fever,
rash, severe muscle pain, and pain and stiffness in the joints.
Treatment is palliative with anti-inflammatory drugs being the
best current treatment (13, 14). RRV-induced arthritis is char-
acterized by inflammatory infiltrates that largely consist of
monocytes/macrophages (9, 15). Newly developed mouse mod-
els of alphavirus arthritis/myositis have increased our under-
standing of the pathogenesis of these viruses and identified
host factors that contribute to the development of RRV-in-
duced disease (26, 31). In outbred mice, RRV-induced disease
was ameliorated after the treatment of mice with macrophage
toxic agents, suggesting a critical role for host immunity and
macrophages in mediating the disease (26). More recently,
C57BL/6 (B6) wild-type and RAG-1/ mice were shown to
develop severe monocytic inflammation of joint, bone, and
skeletal muscle tissue after RRV infection (31), supporting the
concept that innate immune mechanisms play a major role and
that adaptive immunity plays a more limited role in the devel-
opment of RRV-induced inflammatory disease.
The complement system, which consists of greater than 30
soluble and cell surface proteins, is a major component of
innate immunity that functions to recognize and eliminate in-
vading pathogens (reviewed in reference 3). In addition, com-
plement activation regulates downstream adaptive immune re-
sponses. The complement factor C3 functions as the central
player in the complement system as the classical, lectin, and
alternative complement activation pathways all converge on
C3. C3 cleavage products are involved in the opsonization of
pathogens, the attraction and activation of immune cells, and
the amplification of complement activity through the forma-
tion of C3 and C5 convertases. In addition to the roles of the
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complement system in pathogen recognition and immunoregu-
lation, complement has been demonstrated to have a patho-
genic role in ischemic, inflammatory, and autoimmune dis-
eases.
Complement has been demonstrated to play a protective
role in mouse models of some viral infections, including West
Nile virus infection (28, 29) and influenza virus infection (24).
However, the role of complement in alphavirus pathogenesis is
less clear. In mice, complement has been shown to limit the
growth and spread of the Sindbis group alphavirus AR339 (20,
22). Interestingly, complement-depleted mice also had ex-
tended survival times after lethal AR339 infection, suggesting
a potential immunopathologic role for complement. In hu-
mans, studies of RRV-infected patients have thus far failed to
detect evidence of immune complexes in serum or synovial
exudates (10); however, alternative roles for complement in
mediating disease have not been thoroughly investigated.
In the present study, we assessed the role of complement in
the pathogenesis of RRV infection. Similar to wild-type mice,
we found that mice deficient in C3 (C3/) develop inflam-
mation of bone, joint, and skeletal muscle tissue after RRV
infection. However, despite similar virus titers, C3/ mice
exhibited far less severe disease signs and tissue damage com-
pared to wild-type mice, suggesting that complement activation
does not contribute to the recruitment of inflammatory cells
into the RRV-infected tissues but is essential for RRV-in-
duced damage to these tissues. Importantly, we also demon-
strate that complement activation occurs in the joints of RRV-
infected humans, suggesting that complement activation may
play a central role in the pathogenesis of alphavirus-induced
inflammatory disease.
MATERIALS AND METHODS
Viruses and cells. Viral stocks of the T48 strain of RRV were generated by in
vitro transcription off of SacI-linearized plasmid pRR64 (generously provided by
Richard Kuhn, Purdue University), which encodes the full-length T48 cDNA
clone (25), by using SP6-specific mMessage mMachine in vitro transcription kits
(Ambion). The T48 stain of RRV was initially isolated from Aedes vigilax mos-
quitoes in Queensland, Australia (8). Prior to cDNA cloning, the virus was
passaged 10 times in suckling mouse brain, followed by two passages on Vero
cells (6). Full-length transcripts were electroporated into BHK-21 cells (ATCC
CRL 8544) by using a Bio-Rad electroporator as described previously (17).
Culture supernatants were harvested 24 h after electroporation, centrifuged for
20 min at 3,000 rpm, divided into aliquots, and stored at 80°C. Virus was
titrated by plaque assay on BHK-21 cells as described previously (36).
BHK-21 cells were grown in -minimal essential medium (Gibco) supple-
mented with 10% donor calf serum, 10% tryptose phosphate broth, and 0.29 mg
of L-glutamine/ml.
Mice. C3/ and RAG-1/ mice (both on the B6 background) and B6 control
mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and bred
in house. Animal housing and care at the University of North Carolina at Chapel
Hill (UNC) were in accordance with all UNC Institutional Animal Care and Use
Committee guidelines. Although RRV is classified as a biosafety level 2 patho-
gen, due to its exotic nature all mouse studies were performed in a biosafety level
3 laboratory. Mice were inoculated in the left rear footpad with 103 PFU of virus
in diluent (phosphate-buffered saline [PBS]–1% donor calf serum) in a 10-l
volume. Mock-infected animals received diluent alone. Mice were monitored for
disease signs and weighed at 24-h intervals. The clinical signs of disease were
determined by assessing grip strength and altered gait as previously described
(31).
Virus titers. RRV tissue titers were determined by plaque assay on BHK-21
cells as previously described (31).
Histological analysis. Tissues were stained with hematoxylin and eosin (H&E)
and analyzed as previously described (31). For the assessment of Evans blue dye
(EBD) uptake into muscle fibers, 1% EBD (Sigma) in PBS (sterile-filtered) was
injected into the peritoneal cavity of mock- or RRV-infected mice at various
times postinfection. At 6 h postinjection, mice were perfused through the heart
for 10 min with PBS–4% paraformaldehyde (pH 7.3). Quadriceps muscles were
removed, embedded in optimal cutting temperature compound (Tissue-Tek),
and frozen in an isopentane histobath. Cryosections were mounted with DAPI
(4,6-diamidino-2-phenylindole)-containing Vectashield (Vector Laboratories)
and analyzed by fluorescence microscopy. EBD-positive cells showed a bright red
emission.
Immunoblot analysis. Dissected ankles and quadriceps skeletal muscle tissue
were homogenized with 1.0-mm glass beads by using a mini-bead beater (Cole-
Parmer) in radioimmunoprecipitation assay lysis buffer (50 mM Tris [pH 8.0],
150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, and 0.1% sodium dodecyl
sulfate [SDS] supplemented with Complete protease inhibitor cocktail [Roche]).
Total protein concentrations were determined by using the Coomassie Plus assay
kit (Pierce). Dilutions of serum or 20 to 30 g of protein were diluted in an equal
volume of 2 SDS sample buffer, and SDS-polyacrylamide gel electrophoresis
was performed. Proteins were transferred onto polyvinylidene fluoride mem-
branes (Bio-Rad). Membranes were blocked in 1 PBS–5% milk–0.1% Tween
20 and incubated with goat anti-mouse C3 antibody (1:1,000; Cappel) overnight
at 4°C or with anti- tubulin (1:5,000; Sigma) for 1 h at room temperature.
Membranes were washed in PBS–0.1% Tween 20 and incubated with rabbit
anti-goat-horseradish peroxidase (1:10,000; Sigma) for 1 h at room temperature.
After a washing step, proteins were visualized by enhanced chemiluminescence
(Amersham) according to the manufacturer’s instructions.
In situ hybridization. In situ hybridization was performed as described previ-
ously (16). Briefly, an 35S-labeled RRV-specific riboprobe (complementary for
RRV nucleotides 7300 to 7775) was generated with an SP6-specific MAXIscript
in vitro transcription kit (Ambion) from a NotI-linearized plasmid. A riboprobe
complementary for the EBER2 gene from Epstein-Barr virus was used as a
negative control. Deparaffinized tissue sections were hybridized with 5  104 cpm
of 35S-labeled riboprobes/l overnight. Tissues were washed, dehydrated through
graded ethanol, and immersed in NTB autoradiography emulsion (Kodak). After
development, sections were counterstained with hematoxylin, and silver grain
deposition was analyzed by light microscopy.
Cytospins and flow cytometry. Mice were inoculated as described above;
sacrificed by exsanguination at 5, 7, and 10 days postinfection; and perfused for
10 min with 1 PBS. Quadriceps muscles were dissected, minced, and incubated
for 2 h with vigorous shaking at 37°C in digestion buffer (RPMI, 10% fetal bovine
serum, 15 mM HEPES, 2.5 mg of collagenase A [Roche]/ml, 1.7 mg of DNase I
[Sigma]/ml). For cytospins, a portion of the digests was deposited onto glass
slides by centrifugation in the Cytofuge 2 cytocentrifuge system (StatSpin), and
the cells were Wright-Giemsa stained (Sigma). For flow cytometry, cells were
passed through a 70-m-pore-size cell strainer, resuspended in 44% Percoll,
layered on lympholyte-M (Cedarlane), and centrifuged for 30 min at 2,500 rpm.
Banded cells were collected and washed in wash buffer (1 Hanks balanced salt
solution, 15 mM HEPES), and the total viable cells were determined by trypan
blue exclusion. Cells were incubated with anti-mouse FcRII/III (2.4G2; BD
Pharmingen) for 20 min on ice to block nonspecific antibody binding and then
stained in fluorescence-activated cell sorting staining buffer (1 Hanks balanced
salt solution, 1% fetal bovine serum, 2% normal rabbit serum) with the following
antibodies from eBioscience: NK1.1-PE, CD3-fluorescein isothiocyanate, CD4-
biotin, CD8-APC, and CD11b-APC. Biotin conjugates were detected with
Streptavidin-PerCP (eBioscience). Cells were fixed overnight in 2% paraformal-
dehyde and analyzed on a FACSCalibur (Becton Dickinson) by using CellQuest
software.
Patient samples. Synovial aspirates were collected by needle biopsy from five
adult male patients (age range, 30 to 45 years) suffering from acute cases of
RRV-induced polyarthritis and located in the Murray-Goulburn Valley, Victo-
ria, Australia. Collections were carried out at the Royal Melbourne Hospital,
University of Melbourne, Melbourne, Australia. As a control, synovial aspirates
from three osteoarthritis patients were also analyzed. Synovial aspirates from
osteoarthritis patients were obtained from the John James Hospital, Canberra,
Australia. All collections were performed in accordance with the Australian
Capital Territory Health Community Care, Human Research Ethics, and The
Royal Melbourne Hospital Human Ethics Committee and were performed by
trained clinical rheumatologists. Samples were taken at the time of knee joint
arthroplasty, and joints were aspirated prior to arthrotomy. Patients were diag-
nosed as suffering primary osteoarthritis with no evidence of an inflammatory
arthropathy, and none of the patients had taken nonsteroidal anti-inflammatory
drugs in the 8 weeks prior to surgery. After the collection of synovial aspirates,
the cells were separated from the joint fluid by centrifugation. Synovial fluid
samples were stored at 80°C befor measurement of the C3a levels.
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C3a measurement. Measurement of C3a in synovial aspirates was carried out
using a BD OptEIA Human C3a ELISA kit (BD Biosciences) according to the
manufacturer’s instructions. The mean absorbance was calculated for each set of
duplicate standards, controls, and samples, and the C3a concentration of the
samples was determined by using a standard curve.
Statistical analyses. Virus titers and inflammatory cell numbers were evalu-
ated for statistically significant differences by unpaired t tests using GraphPad
InStat3 software. For C3a analysis and clinical scores, data were statistically
analyzed by the Mann-Whitney test using GraphPad InStat3 software. A P value
of 0.05 was considered significant.
RESULTS
C3/ mice develop less severe disease following RRV in-
fection. Previous studies demonstrated that 24-day-old B6 mice
infected with RRV developed severe disease characterized by
loss of hind limb gripping ability, altered gait, and lack of
weight gain, and these disease signs correlated with severe
inflammation of bone, joint, and skeletal muscle tissue (31).
Since complement has been shown to play an important role in
inflammatory cell recruitment in numerous model systems,
studies were initiated to assess the role of complement in RRV
pathogenesis. 24-day-old mice deficient in the complement
component C3 (C3/) and control B6 mice were infected with
1000 PFU of RRV and mice were monitored for the develop-
ment of disease signs. As previously reported, infection of
wild-type B6 mice resulted in severe disease with peak clinical
scores at day 10 (5.7  0.75) and day 12 (5.8  1.2) postinfec-
tion (Fig. 1A). In contrast, only very mild signs of disease were
observed in RRV-infected C3/ mice at day 10 (1.0  0.9)
and day 12 (0.7  0.6) postinfection (Fig. 1A). In addition,
RRV-infected B6 mice lost weight between 7 and 12 days
postinfection (dpi), which correlated with peak clinical scores,
whereas RRV-infected C3/ mice did not lose weight at any
time during the infection and in fact showed only a slightly
slower rate of weight gain compared to mock-infected mice
(Fig. 1B). Interestingly, the role of complement in RRV-in-
duced disease is likely to be antibody-independent since RAG-
1/ mice (31), as well as MT mice (data not shown), develop
RRV disease similar to wild-type B6 mice.
Complement is activated in response to RRV infection. To
determine whether the complement system was activated dur-
ing RRV infection, immunoblot analyses were performed to
detect C3 activation products in serum samples collected from
mock-infected and RRV-infected mice at various times postin-
fection. C3 activation products were not detected in the serum
at 2 dpi (the time point of peak virus titers in the serum) (31)
or 5 dpi (data not shown). However, by 7 dpi immunoblot
analyses detected an increase in fragments of C3 in the se-
rum, including C3d and C3c (Fig. 2A). Next, immunoblot anal-
yses were performed on homogenates of ankle joint tissues and
skeletal muscle tissues harvested from perfused mock- or
RRV-infected mice. An increase in total C3 (	C3 and C3)
and a fragment of the C3 activation product iC3b were de-
tected at 7 dpi in both ankle (Fig. 2B) and quadriceps muscle
tissue (Fig. 2C) compared to mock-infected controls. The C3
activation product iC3b was also detected in joint and skeletal
muscle tissues harvested from perfused RRV-infected RAG-
1/ mice (Fig. 2B and C), indicating that the complement
system is activated in a T- and B-lymphocyte-independent
manner in RRV-infected mice.
Viral burdens and tissue tropism are similar in wild-type
and C3/ mice. The primary targets of RRV replication in
vivo are cells within the periosteum and synovial tissue of bone
and joints, cells within the perimysium, and skeletal muscle
myofibers (31). To determine whether differences in virus titers
within these tissues could explain the reduced severity of dis-
ease observed in RRV-infected C3/ mice, plaque assays
were performed to compare the amount of infectious virus in
joint and skeletal muscle tissues of RRV-infected B6 and
C3/ mice at 1, 2, 3, 4, and 7 dpi. Significantly higher RRV
titers were detected in ankle and quadriceps muscle tissue
from wild-type mice at day 1 postinfection (Fig. 3A and B), and
this difference was consistent in both limbs. The only statisti-
cally significant difference detected at days 2, 3, 4, and 7 postin-
fection was in quadriceps muscle tissue from the right hind-
limb at 3 dpi, in which C3/ mice had slightly lower virus
titers (Fig. 3C); however, no difference was detected in quad-
riceps muscle tissue from the left hind limb at this time point
FIG. 1. RRV-induced disease is less severe in C3/ mice. Twenty-
four-day-old C57BL/6J wild-type (WT) or C3/ mice were inoculated
with 103 PFU of RRV by injection in the left rear footpad. Mock-
infected mice were injected with diluent alone. (A) Mice were scored
for the development of hind-limb dysfunction and disease based on the
following scale: 0, no disease signs; 1, ruffled fur; 2, very mild hind-limb
weakness; 3, mild hind-limb weakness; 4, moderate hind-limb weak-
ness and dragging of hind limbs; 5, severe hind-limb weakness and/or
dragging; 6, complete loss of hind limb function; 7, moribund; and 8,
death. Each datum point represents the arithmetic mean  the SD of
4 (mock), 6 (wild type  RRV), or 11 (C3/  RRV) mice and are
representative of three independent experiments. , P 
 0.001.
(B) Mice were monitored for weight gain or loss at 24-h intervals. Each
datum point represents the arithmetic mean  the standard deviation
of 4 (mock), 6 (wild type  RRV), or 11 (C3/  RRV) mice and are
representative of three independent experiments.
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(Fig. 3B and D). Importantly, virus titers in B6 and C3/ mice
at 7 dpi, a time point that correlates with significant disease
signs in wild-type mice, were similar in all tissues examined
(Fig. 3).
The analysis of viral loads by plaque assay indicated that
RRV-infected B6 and C3/ mice had similar levels of viral
replication within the inflamed tissues at 2, 3, 4, and 7 dpi.
However, the genetic deficiency of C3 could alter viral tropism
for specific cells within tissues, and this potential difference
would not be detected by plaque assay. Therefore, the specific
sites of RRV replication in B6 and C3/ mice were assessed
by in situ hybridization on sections derived from ipsilateral and
contralateral (relative to injection) hind-limb tissues using an
35S-labeled riboprobe specific for RRV. At 24 h postinfection
(hpi), RRV-specific signal was detected within cells of the
periosteum lining bones of the hind limbs and cells within
synovial tissue of the ankle joint in both B6 and C3/ mice
(Fig. 4A). In addition, RRV-specific signal was detected in the
perimysium of the quadriceps muscle of both strains of mice at
24 hpi (Fig. 4B). By 48 to 120 hpi, RRV-specific signal was
detected in the skeletal muscle fibers of wild-type mice, indi-
cating that the virus had spread from muscle connective tissues
into muscle fibers. A similar distribution of RRV replication
was detected in the skeletal muscle of RRV-infected C3/
mice. However, at 48 hpi in C3/ mice RRV-specific in situ
signal was still confined to skeletal muscle connective tissues
with spread into muscle fibers occurring by 72 hpi (Fig. 4B). No
signal was detected in tissue sections from infected animals
hybridized with a riboprobe specific for the EBER2 gene from
Epstein-Barr virus (Fig. 4B) or in tissues from mock-infected
animals hybridized with the RRV-specific riboprobe (data not
shown). In addition, the sites of viral replication identified at
each time point examined were similar in ipsilateral and con-
tralateral tissues. These finding indicate that in the absence of
C3 there may be a slight lag in muscle fiber infection, but the
sites of RRV replication within hind-limb tissues were not
altered.
RRV infection induces inflammation but less severe tissue
destruction in C3/ mice. RRV-induced inflammation in
bone, joint, and skeletal muscle tissues of B6 mice is most
severe at 7 to 10 dpi and resolves by 20 to 30 dpi (31). To
compare tissue inflammation and pathology in RRV-infected
C3/ mice and control B6 mice, histological analyses of hind
limb joint and skeletal muscle tissues were performed by stain-
ing fixed sections with H&E. Inflammation was not observed in
synovial tissue or quadriceps skeletal muscle tissue from mock-
infected mice (Fig. 5). In contrast, severe inflammation was
observed in synovial tissue at 7 dpi (Fig. 5A). Inflammatory
infiltrates were also observed in synovial tissue of RRV-in-
fected C3/ mice (Fig. 5A), suggesting that C3 is not required
for inflammatory cell recruitment into the joints after RRV
infection. Similarly, inflammatory infiltrates were also ob-
served in quadriceps skeletal muscle tissue of RRV-infected
wild-type and C3/ mice at 7 and 10 dpi (Fig. 5B and C).
Strikingly, despite the presence of large numbers of inflamma-
tory infiltrates, skeletal muscle tissue pathology appeared to be
much less severe in tissues from RRV-infected C3/ mice
than in tissues from RRV-infected wild-type mice (Fig. 5B and
C). To confirm that RRV infection of C3/ mice results in
less severe tissue pathology, quadriceps muscle tissue was ex-
amined at 20 dpi, a time point at which inflammation has
resolved but tissue damage can be observed. In RRV-infected
B6 mice, numerous areas of severely damaged skeletal muscle
tissue were distributed throughout the sections (Fig. 6A and
B). In addition, large numbers of myofibers with centralized
nuclei were evident (the hallmark of skeletal muscle regener-
ation) (4, 38), suggesting that wide-scale injury had taken place
(Fig. 6C). In contrast, neither severely damaged areas of the
skeletal muscle tissue (Fig. 6D and E) nor large numbers of
myofibers with centralized nuclei (Fig. 6F) were observed in
sections from the quadriceps muscle of RRV-infected C3/
FIG. 2. Complement is activated during RRV infection. Twenty-
four-day-old C57BL/6J wild-type, C3/, or RAG-1/ mice were in-
fected with 103 PFU of RRV by injection in the left rear footpad. At
7 dpi, mice were euthanized, serum was collected, mice were perfused
with 1 PBS, and the left ankle or quadriceps muscle was homoge-
nized in radioimmunoprecipitation assay lysis buffer. Immunoblot
analyses were performed with polyclonal anti-murine C3 antibody
(Cappel) or an anti--tubulin antibody as described in Materials and
Methods. (A) Serum; (B) ankle tissue; (C) quadriceps muscle tissue.
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mice at 20 dpi. These data suggest that although RRV infec-
tion induces inflammation in C3/ mice similar to that ob-
served in wild-type mice, tissue damage is much less severe.
These results are consistent with the less severe disease signs
observed in RRV-infected C3/ mice and suggest an impor-
tant role for the complement system in regulating the nature of
the RRV-induced inflammatory response.
To further confirm that RRV infection results in less severe
damage to skeletal muscle tissue in C3/ mice compared to
wild-type mice, EBD uptake was utilized to detect damaged
muscle fibers in vivo. At 10 and 12 dpi (time points when
RRV-induced disease signs are most severe), mock- and RRV-
infected mice were injected intraperitoneally with 1% EBD.
Six hours later the mice were perfused with 4% paraformal-
dehyde, frozen sections were generated, and EBD-positive
cells (which show a bright red emission) were identified by
fluorescence microscopy. Abundant EBD-positive muscle fi-
bers were evident in sections generated from the quadriceps
muscle of RRV-infected B6 mice at both 10 and 12 dpi (Fig. 7),
whereas only sporadic EBD-positive fibers were detected in
similar sections from RRV-infected C3/ mice (Fig. 7). These
data, together with the histological analyses, indicate that in
the absence of an intact complement system RRV infection
induces inflammation of joint and muscle tissue; however, this
inflammation is far less destructive than that observed in the
presence of an intact complement system.
The kinetics of inflammation and composition of inflamma-
tory infiltrates is similar in RRV-infected wild-type and C3/
mice. The histological and EBD studies suggested that RRV
infection induces inflammatory infiltrates without severe tissue
destruction in C3/ mice. However, it is difficult to determine
from these studies the total number and/or the composition of
those cellular infiltrates, and changes in either could explain
the difference in tissue damage observed between wild-type
and C3/ mice. Previous studies in humans and mice have
demonstrated that RRV-induced inflammation is composed
almost entirely of mononuclear infiltrates with a distinct lack of
neutrophils (9, 15, 26, 31, 35). To confirm these findings, dif-
ferential cell counts were performed on Giemsa-stained cyto-
spins of collagenase-digested quadriceps muscle tissue from
wild-type mice, a procedure that has been successfully used to
isolate viable neutrophils (5). At 5 and 7 dpi, 98% of total
leukocytes were mononuclear, and the vast majority of these
cells were highly vacuolated macrophages (data not shown).
Based on these findings, the composition of mononuclear
inflammatory infiltrates in wild-type and C3/ mice was de-
FIG. 3. RRV titers in ankle and skeletal muscle tissue. 24-day-old C57BL/6J wild-type (F) or C3/ mice (E) were infected with 103 PFU of
RRV by injection in the left rear footpad. At 1 dpi (n  8 to 9), 2 dpi (n  7 to 8), 3 dpi (n  8 to 9), 4 dpi (n  6), and 7 dpi (n  6 to 7) the
ankle and quadriceps muscle tissues were harvested and homogenized, and the amount of infectious virus present was quantified by plaque assay
on BHK-21 cells. (A) Ankle (injected leg); (B) quadriceps muscle (injected leg); (C) ankle (noninjected leg); (D) quadriceps muscle (noninjected
leg). The results are from two to three paired experiments, and a single animal is represented by one circle in each panel. , P 
 0.05.
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termined at various times postinfection. Single cell suspensions
were generated from quadriceps muscle tissue from each of the
hind limbs of RRV-infected wild-type and C3/ mice. The
total leukocyte numbers were determined, and isolated cells
were analyzed by flow cytometry. At 5, 7, and 10 dpi no sta-
tistically significant difference in the total number of cellular
inflammatory infiltrates in RRV-infected wild-type and C3/
mice was detected (Fig. 8A).
FIG. 4. RRV infection in hind limb bone, joint, and skeletal muscle. Twenty-four-day-old C57BL/6J wild-type or C3/ mice were infected with
103 PFU of RRV by injection in the left rear footpad. Mice were sacrificed at 24, 48, 72, 96, and 120 hpi and perfused with 4% paraformaldehyde.
After decalcification of calcified tissues, 5-m-thick paraffin-embedded sections derived from the hind limbs were probed with an 35S-labeled
riboprobe complementary either to RRV or to the EBER2 gene from Epstein-Barr virus (control probe). (A) RRV-specific in situ signal in bones
and joints of foot at 24 hpi. Two panels per strain showing signal in the periosteum (left panels) or synovial tissue (right panels) are presented.
(B) RRV-specific in situ signal in quadriceps muscle tissue.
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Next, flow cytometry was performed to determine the pro-
portion of macrophages, natural killer (NK) cells, and CD4
and CD8 T lymphocytes in the inflammatory infiltrates.
These cell types were previously demonstrated to comprise the
majority of the RRV-induced inflammatory infiltrate (31). At 7
dpi, the percentage and total number of CD11b inflammatory
infiltrates were similar in RRV-infected wild-type and C3/
mice (Fig. 8B and C and Table 1). In addition, the percentages
FIG. 5. RRV-induces inflammation in wild-type and C3/ mice. Twenty-four-day-old C57BL/6J wild-type or C3/ mice were infected with
103 PFU of RRV by injection in the left rear footpad. Mock-infected mice were injected with diluent alone. (A) At 7 dpi mice were perfused with
4% paraformaldehyde. After decalcification, 5-m-thick paraffin-embedded sections generated from ankle and foot tissues of the ipsilateral and
contralateral leg (relative to injection site) of mock- and RRV-infected mice were stained with H&E. The images shown are from the ipsilateral
leg and are representative of at least 6 mice per group. (B and C) At 7 and 10 days postinfection mice were perfused with 4% paraformaldehyde.
Paraffin-embedded sections (5-m thick) were generated from the quadriceps muscles of mock- or RRV-infected mice as in panel A and were
stained with H&E. The images are representative of at least six mice per group.
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and total numbers of NK cells (NK1.1/CD3) and total
CD3 T lymphocytes was also similar in RRV-infected wild-
type and C3/ mice (Fig. 8B, 8C, and Table 1). Interestingly,
the percentage of CD4 T lymphocytes was greater in inflam-
matory infiltrates isolated from RRV-infected C3/ mice. In
contrast, RRV-infected wild-type mice had a greater percent-
age and greater number of CD8 T lymphocytes at this time
point. The percentages and total numbers of CD11b,
NK1.1/CD3, and CD3 cells in RRV-infected wild-type and
C3/ were also similar at 5 dpi (data not shown). Although a
difference in a specific cell type not analyzed here cannot be
ruled out, these data indicate that the overall kinetics, degree,
and composition of RRV-induced inflammation are similar in
wild-type and C3/ mice, indicating that complement is not
critical for the recruitment of cells to the inflammatory site.
However, in the absence of an intact complement system, the
destructive nature of the inflammation is severely attenuated.
Complement is activated in joints of RRV-infected humans.
The data presented thus far suggest that the complement sys-
tem contributes to the severity of RRV-induced disease in
mice; however, whether complement contributes to RRV-in-
duced disease in humans is not well understood. Although
immune complexes have not been detected in RRV-infected
patients, a role for complement cannot be ruled out. In this
regard, the C3a levels (a marker of C3 processing) in synovial
fluid from RRV patients suffering from RRV-induced polyar-
thritis were assessed and compared to synovial fluid from hu-
mans with noninflammatory osteoarthritis. Synovial fluid from
persons suffering from acute RRV-induced polyarthritis exhib-
ited significantly higher levels of C3a compared to samples
from osteoarthritis patients (Fig. 9). Differences in C3a levels




We present data here that (i) demonstrate that infection of
humans and mice with RRV results in activation of the com-
plement system and (ii) establish an important role for the
complement system in inflammatory tissue damage associated
with RRV infection in mice. These studies, in addition to our
previous work, indicate that RRV infection of B6 mice reca-
pitulates many aspects of the human disease and thus serves as
FIG. 6. Skeletal muscle damage is less severe in C3/ mice. Twenty-
four-day-old C57BL/6J wild-type or C3/ mice were infected with 103
PFU of RRV by injection in the left rear footpad. At 20 dpi the mice were
perfused with 4% paraformaldehyde, and 5-m-thick paraffin-embedded
sections generated from the quadriceps muscle of RRV-infected mice
were stained with H&E. The images (magnification, 200) are represen-
tative of at least six mice per group.
FIG. 7. RRV-induced tissue damage is less severe in C3/ mice. Twenty-four-day-old C57BL/6J wild-type and C3/ mice were mock infected
or infected with 103 PFU of RRV by injection in the left rear footpad. At 10 and 12 dpi, mice were injected intraperitoneally with 1% EBD, and
6 h later mice were perfused with 4% paraformaldehyde. Quadriceps muscle tissue was removed, and 10-m frozen sections were generated. The
uptake of EBD (upper panels) and DAPI (lower panels) was visualized by fluorescence microscopy. Images (magnification, 100) are represen-
tative of three mice per group.
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FIG. 8. Complement is not required for inflammatory cell recruitment in Ross river virus-infected mice. Twenty-four-day-old C57BL/6J WT
and C3/ mice were infected with 103 PFU of RRV by injection in the left rear footpad. (A) At 5, 7, and 10 dpi infiltrating cells were isolated
from quadriceps muscle tissue as described in Materials and Methods, and the total cell number was determined. Differences were not statistically
different by t test. (B) Cell surface staining of cells isolated from the quadriceps muscle at 7 dpi. Dot plots shown are representative of three mice.
Two independent experiments gave similar results. (C) Total numbers of CD11b, NK1.1/CD3, CD3, CD3/CD4, and CD3/CD8 cells
isolated from the quadriceps muscle of RRV-infected wild-type (■ ) and C3/ () mice at 7 dpi. The data presented are the means  the standard
errors of the mean of three mice per group and are representative of two independent experiments. , P 
 0.05.
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an accurate model to study the pathogenesis of arthritogenic
alphaviruses. The contribution of complement to tissue injury
in this model was independent of inflammatory cell recruit-
ment since both wild-type and C3/ mice displayed similar
kinetics and compositions of cellular infiltrates at the inflam-
matory site.
Although complement has been reported to play a protec-
tive role in mouse models of West Nile virus infection (28, 29),
influenza virus infection (24), and vesicular stomatitis virus
infection (32), complement activation may be associated with
more severe forms of other viral diseases, including dengue
virus-induced disease and enhanced respiratory syncytial virus
disease (ERD). Complement consumption has been observed
in patients with dengue shock syndrome, a severe form of
dengue virus infection that leads to vascular leakage, hypoten-
sion, and shock (2), and plasma SC5b-9 levels have been found
to correlate with dengue hemorrhagic fever and dengue shock
syndrome disease severity (1). In addition, bronchoconstriction
in a mouse model of ERD was demonstrated to be comple-
ment and antibody dependent, supporting an important role
for immune complex formation and complement activation in
the pathogenesis of ERD (33).
In addition to our studies that implicate complement in
alphavirus-induced arthritis, complement has been implicated
in other mouse models of arthritic disease. Complement con-
tributes to both the inductive phase (via C3d enhancement of
B-cell responses) (7) and the inflammatory phase of type II
collagen-induced arthritis. In contrast to our findings, which
demonstrate a role for complement independent of inflamma-
tory cell recruitment, complement activation in collagen-in-
duced arthritis, as well as type II collagen MAb-induced ar-
thritis, plays a critical role in the recruitment of cellular
infiltrates into the affected joints (11, 18, 39).
Comparative analyses of the RRV-induced inflammatory
infiltrates did not detect any major differences in wild-type or
C3/ mice with respect to kinetics, the number of infiltrating
cells, or the composition of inflammatory infiltrates, although
differences in a minor cellular component not examined here
cannot be ruled out. Importantly, similar numbers of macro-
phages, the predominate cell type observed in synovial fluid of
RRV-infected patients (9), were isolated from the inflamed
tissue of both wild-type and C3/ mice at 5 and 7 dpi. Inter-
estingly, although similar numbers of total CD3 skeletal mus-
cle infiltrates were detected in both strains, the percentage of
CD3/CD4 cells was higher in RRV-infected C3/ mice
than in wild-type mice. Conversely, the percentage of CD3/
CD8 cells was lower in RRV-infected C3/ mice than in
wild-type mice. These differences probably do not explain the
difference in RRV-induced disease observed in wild-type and
C3/ mice, since both RAG-1/ mice (31) and CD8/ mice
(unpublished observations) develop disease similar to that in-
duced in wild-type mice. However, these results suggest a pos-
sible immunoregulatory role for complement during RRV-
induced disease.
The histological analyses and EBD uptake studies reported
here demonstrate a clear role for complement in mediating
tissue injury after RRV infection. Although we cannot rule out
that the differences in viral burdens detected at 1 dpi may have
affected later phases of the disease, the differences in tissue
injury are unlikely to be due solely to differences in viral loads
since similar levels of viral replication were detected in the
inflamed tissues of wild-type and C3/ mice at 2, 3, 4, and 7
dpi. The mechanism(s) by which complement mediates en-
hanced tissue injury in RRV-infected mice is still under inves-
tigation. Beyond their well-established roles in inflammatory
cell recruitment, complement activation products induce cel-
lular activation and promote the release of potent inflamma-
tory molecules capable of enhancing tissue destruction, includ-
ing reactive oxygen intermediates and proteolytic enzymes. A
previous study demonstrated that treatment of mice with mac-
rophage toxic agents prevented development of RRV-induced
disease, indicating a critical role for macrophages (26). Thus, it
is possible that complement activation products regulate the
effector functions of inflammatory macrophages (the predom-
inate RRV-induced cellular infiltrate) or other cellular infil-
trates by engagement of complement receptors such as CR3 or
CR4. Support for a similar idea has been demonstrated in a
model of thrombohemorrhagic vasculitis in which interaction
of the C3 split product iC3b with CR3 expressed on infiltrating
neutrophils was found to be critical for blood vessel injury (19).
Alternatively, RRV-induced formation of the membrane at-
FIG. 9. C3a levels are higher in synovial fluid from humans suffer-
ing from RRV-induced polyarthritis than in synovial fluid from hu-
mans with noninflammatory osteoarthritis. Synovial fluid samples from
five individuals diagnosed with acute RRV-induced polyarthritis and
three individuals with osteoarthritis were assessed for C3a levels using
a Human C3a EIA kit (BD Biosciences). The data are presented as
mean C3a levels (in ng/ml) in synovial fluid. The differences in C3a
levels in RRV versus osteoarthritis samples were statistically signifi-
cant (P 
 0.05) as determined by the Mann-Whitney U test.
TABLE 1. Cell type percentages of inflammatory infiltrates
Cell type
Mean % of culture  SD
Wild type C3/
CD11b 59.2  4.2 55.2  0.0
NK1.1/CD3 6.0  0.4 8.0  0.0
CD3/NK1.1 14.5  0.4 16.6  0.3
CD3 CD8 (% of total) 6.9  0.5 5.2  0.3
CD3 CD4 (% of total) 5.4  0.2 9.3  0.2
CD3 CD8 (% of CD3) 47.7  0.4 28.5  0.8
CD3 CD4 (% of CD3) 37.4  0.5 56.1  0.7
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tack complex, which is composed of the terminal complement
components that participate directly in cell killing when
present in lytic amounts, could also lead to exacerbated tissue
injury.
Our immunoblot analyses in wild-type and RAG-1/ mice
indicate that complement activation is detectable within the
injured tissues at late times postinfection. The kinetics of this
activation correlates with the development of inflammation
and detectable signs of disease. In addition, complement acti-
vation products were not detectable in serum from RRV-in-
fected mice until day 7 postinfection, a time point that occurs
a full 5 days after peak serum viremia. The pathway(s) by
which RRV infection stimulates complement activation is cur-
rently under investigation. The detection of complement acti-
vation products in joint and muscle tissue derived from RRV-
infected RAG-1/ mice indicates that immune complexes are
not required for RRV-induced complement activation. These
findings are consistent with the lack of detection of immune
complexes in synovial fluid from RRV-infected patients (10).
Consistent with these findings, Sindbis virus, a related alpha-
virus, has been demonstrated to activate both the alternative
and the classical (C4-dependent) complement activation path-
ways in an antibody-independent manner (23). Our prelimi-
nary results suggest that RRV-induced disease is not affected
by the genetic ablation of factor B, a critical component of the
alternative complement activation pathway. Therefore, there
may be an important role for a lectin-dependent pathway or
other C4-dependent pathways in mediating complement acti-
vation after RRV infection. Interestingly, the glycosylation sta-
tus of Sindbis virus particles was shown to influence the ability
of the virus to activate complement (21), suggesting that al-
phavirus glycoproteins may interact with the host complement
system. Future studies are needed to assess the role of RRV
glycoproteins and glycoprotein glycosylation in mediating
RRV-induced complement activation and disease.
In addition to our studies with mice, we present evidence of
complement activation in the synovial fluid of RRV-infected
patients. The levels of C3a, a marker of C3 processing, were
elevated in samples from RRV-infected patients compared to
C3a detected in samples derived from patients diagnosed with
osteoarthritis. This is the first demonstration that infection
with an arthritogenic alphavirus results in complement activa-
tion within the joints. Although the role of complement in
mediating joint pain in RRV-infected humans cannot be de-
termined from these studies, these data suggest that our find-
ings in the mouse model are consistent with at least some
aspects of the human disease.
In summary, the complement system has been implicated in
the pathogenesis of a number of inflammatory diseases, includ-
ing other arthritides (27, 30, 40); however, the role of comple-
ment in virus-induced arthritic disease has not been well stud-
ied. The findings reported here support an important role for
complement in the tissue destruction phase of RRV-induced
inflammatory disease that is independent of inflammatory cell
recruitment. Future studies directed at assessing the role of
complement in alphavirus-induced arthritic disease in humans,
such as those caused by RRV and chikungunya virus, may lead
to the development of better treatments and therapeutics.
ACKNOWLEDGMENTS
This research was supported by NIH research grant R01 AR47190
and NHMRC grant 303404 (to S.M.). S.M. is the recipient of an
NHMRC RD Wright Fellowship. T.E.M. was supported by NIH post-
doctoral fellowship F32 AR052600-01.
We thank members of the Carolina Vaccine Institute and the John-
ston laboratory for helpful scientific discussions. We thank Nancy
Davis for critical reading of the manuscript. We also thank Janice
Weaver, Robin Smith, and Wuhan Jiang at the LCCC/DLAM UNC
histopathology core facility.
REFERENCES
1. Avirutnan, P., N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K.
Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C.
Puttikhunt, S. N. Pattanakitsakul, P. T. Yenchitsomanus, J. Mongkolsa-
paya, W. Kasinrerk, N. Sittisombut, M. Husmann, M. Blettner, S. Vasana-
wathana, S. Bhakdi, and P. Malasit. 2006. Vascular leakage in severe dengue
virus infections: a potential role for the nonstructural viral protein NS1 and
complement. J. Infect. Dis. 193:1078–1088.
2. Bokisch, V. A., F. H. Top, Jr., P. K. Russell, F. J. Dixon, and H. J. Muller-
Eberhard. 1973. The potential pathogenic role of complement in dengue
hemorrhagic shock syndrome. N. Engl. J. Med. 289:996–1000.
3. Carroll, M. C. 2004. The complement system in regulation of adaptive
immunity. Nat. Immunol. 5:981–986.
4. Charge, S. B., and M. A. Rudnicki. 2004. Cellular and molecular regulation
of muscle regeneration. Physiol. Rev. 84:209–238.
5. Cotter, M. J., and D. A. Muruve. 2006. Isolation of neutrophils from mouse
liver: a novel method to study effector leukocytes during inflammation.
J. Immunol. Methods 312:68–78.
6. Dalgarno, L., C. M. Rice, and J. H. Strauss. 1983. Ross River virus 26 s
RNA: complete nucleotide sequence and deduced sequence of the encoded
structural proteins. Virology 129:170–187.
7. Del Nagro, C. J., R. V. Kolla, and R. C. Rickert. 2005. A critical role for
complement C3d and the B-cell coreceptor (CD19/CD21) complex in the
initiation of inflammatory arthritis. J. Immunol. 175:5379–5389.
8. Doherty, R. L., R. H. Whitehead, B. M. Gorman, and A. K. O’Gower. 1963.
The isolation of a third group A arbovirus in Australia, with preliminary
observations on its relationship to epidemic polyarthritis. Aust. J. Sci. 26:
183–184.
9. Fraser, J. R., A. L. Cunningham, B. J. Clarris, J. G. Aaskov, and R. Leach.
1981. Cytology of synovial effusions in epidemic polyarthritis. Aust. N. Z. J.
Med. 11:168–173.
10. Fraser, J. R., A. L. Cunningham, J. D. Mathews, and A. Riglar. 1988.
Immune complexes and Ross River virus disease (epidemic polyarthritis).
Rheumatol. Int. 8:113–117.
11. Grant, E. P., D. Picarella, T. Burwell, T. Delaney, A. Croci, N. Avitahl, A. A.
Humbles, J. C. Gutierrez-Ramos, M. Briskin, C. Gerard, and A. J. Coyle.
2002. Essential role for the C5a receptor in regulating the effector phase of
synovial infiltration and joint destruction in experimental arthritis. J. Exp.
Med. 196:1461–1471.
12. Griffin, D. E. 2001. Alphaviruses, p. 917–962. In D. M. Knipe and P. M.
Howley (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Phila-
delphia, PA.
13. Harley, D., D. Bossingham, D. M. Purdie, N. Pandeya, and A. C. Sleigh.
2002. Ross River virus disease in tropical Queensland: evolution of rheu-
matic manifestations in an inception cohort followed for six months. Med. J.
Aust. 177:352–355.
14. Harley, D., A. Sleigh, and S. Ritchie. 2001. Ross River virus transmission,
infection, and disease: a cross-disciplinary review. Clin. Microbiol. Rev. 14:
909–932.
15. Hazelton, R. A., C. Hughes, and J. G. Aaskov. 1985. The inflammatory
response in the synovium of a patient with Ross River arbovirus infection.
Aust. N. Z. J. Med. 15:336–339.
16. Heise, M. T., D. A. Simpson, and R. E. Johnston. 2000. Sindbis-group
alphavirus replication in periosteum and endosteum of long bones in adult
mice. J. Virol. 74:9294–9299.
17. Heise, M. T., L. J. White, D. A. Simpson, C. Leonard, K. A. Bernard, R. B.
Meeker, and R. E. Johnston. 2003. An attenuating mutation in nsP1 of the
Sindbis-group virus S.A.AR86 accelerates nonstructural protein processing
and up-regulates viral 26S RNA synthesis. J. Virol. 77:1149–1156.
18. Hietala, M. A., I. M. Jonsson, A. Tarkowski, S. Kleinau, and M. Pekna. 2002.
Complement deficiency ameliorates collagen-induced arthritis in mice. J. Im-
munol. 169:454–459.
19. Hirahashi, J., D. Mekala, J. Van Ziffle, L. Xiao, S. Saffaripour, D. D.
Wagner, S. D. Shapiro, C. Lowell, and T. N. Mayadas. 2006. Mac-1 signaling
via Src-family and Syk kinases results in elastase-dependent thrombohem-
orrhagic vasculopathy. Immunity 25:271–283.
20. Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1978. The effect of
complement depletion on the course of Sindbis virus infection in mice.
J. Immunol. 121:1276–1278.
5142 MORRISON ET AL. J. VIROL.
21. Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1981. Host modification
of Sindbis virus sialic acid content influences alternative complement path-
way activation and virus clearance. J. Immunol. 127:1740–1743.
22. Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1980. The role of com-
plement in viral infections. II. The clearance of Sindbis virus from the
bloodstream and central nervous system of mice depleted of complement.
J. Infect. Dis. 141:212–217.
23. Hirsch, R. L., J. A. Winkelstein, and D. E. Griffin. 1980. The role of com-
plement in viral infections. III. Activation of the classical and alternative
complement pathways by Sindbis virus. J. Immunol. 124:2507–2510.
24. Kopf, M., B. Abel, A. Gallimore, M. Carroll, and M. F. Bachmann. 2002.
Complement component C3 promotes T-cell priming and lung migration to
control acute influenza virus infection. Nat. Med. 8:373–378.
25. Kuhn, R. J., H. G. Niesters, Z. Hong, and J. H. Strauss. 1991. Infectious
RNA transcripts from Ross River virus cDNA clones and the construction
and characterization of defined chimeras with Sindbis virus. Virology 182:
430–441.
26. Lidbury, B. A., C. Simeonovic, G. E. Maxwell, I. D. Marshall, and A. J.
Hapel. 2000. Macrophage-induced muscle pathology results in morbidity and
mortality for Ross River virus-infected mice. J. Infect. Dis. 181:27–34.
27. Makinde, V. A., G. Senaldi, A. S. Jawad, H. Berry, and D. Vergani. 1989.
Reflection of disease activity in rheumatoid arthritis by indices of activation
of the classical complement pathway. Ann. Rheum. Dis. 48:302–306.
28. Mehlhop, E., and M. S. Diamond. 2006. Protective immune responses
against West Nile virus are primed by distinct complement activation path-
ways. J. Exp. Med. 203:1371–1381.
29. Mehlhop, E., K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S.
Diamond. 2005. Complement activation is required for induction of a pro-
tective antibody response against West Nile virus infection. J. Virol. 79:7466–
7477.
30. Morgan, B. P., R. H. Daniels, and B. D. Williams. 1988. Measurement of
terminal complement complexes in rheumatoid arthritis. Clin. Exp. Immu-
nol. 73:473–478.
31. Morrison, T. E., A. C. Whitmore, R. S. Shabman, B. A. Lidbury, S.
Mahalingam, and M. T. Heise. 2006. Characterization of Ross River virus
tropism and virus-induced inflammation in a mouse model of viral arthritis
and myositis. J. Virol. 80:737–749.
32. Ochsenbein, A. F., D. D. Pinschewer, B. Odermatt, M. C. Carroll, H.
Hengartner, and R. M. Zinkernagel. 1999. Protective T cell-independent
antiviral antibody responses are dependent on complement. J. Exp. Med.
190:1165–1174.
33. Polack, F. P., M. N. Teng, P. L. Collins, G. A. Prince, M. Exner, H. Regele,
D. D. Lirman, R. Rabold, S. J. Hoffman, C. L. Karp, S. R. Kleeberger, M.
Wills-Karp, and R. A. Karron. 2002. A role for immune complexes in
enhanced respiratory syncytial virus disease. J. Exp. Med. 196:859–865.
34. Schuffenecker, I., I. Iteman, A. Michault, S. Murri, L. Frangeul, M. C.
Vaney, R. Lavenir, N. Pardigon, J. M. Reynes, F. Pettinelli, L. Biscornet, L.
Diancourt, S. Michel, S. Duquerroy, G. Guigon, M. P. Frenkiel, A. C. Brehin,
N. Cubito, P. Despres, F. Kunst, F. A. Rey, H. Zeller, and S. Brisse. 2006.
Genome microevolution of chikungunya viruses causing the Indian Ocean
outbreak. PLoS Med. 3:e263.
35. Seay, A. R., D. E. Griffin, and R. T. Johnson. 1981. Experimental viral
polymyositis: age dependency and immune responses to Ross River virus
infection in mice. Neurology 31:656–660.
36. Simpson, D. A., N. L. Davis, S. C. Lin, D. Russell, and R. E. Johnston. 1996.
Complete nucleotide sequence and full-length cDNA clone of S.A.AR86, a
South African alphavirus related to Sindbis. Virology 222:464–469.
37. Suhrbier, A., and M. La Linn. 2004. Clinical and pathologic aspects of
arthritis due to Ross River virus and other alphaviruses. Curr. Opin. Rheu-
matol. 16:374–379.
38. Tidball, J. G. 2005. Inflammatory processes in muscle injury and repair.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R345–R353.
39. Wang, Y., S. A. Rollins, J. A. Madri, and L. A. Matis. 1995. Anti-C5 mono-
clonal antibody therapy prevents collagen-induced arthritis and ameliorates
established disease. Proc. Natl. Acad. Sci. USA 92:8955–8959.
40. Ward, P. A., and N. J. Zvaifler. 1971. Complement-derived leukotactic fac-
tors in inflammatory synovial fluids of humans. J. Clin. Investig. 50:606–616.
41. Williams, M. C., J. P. Woodall, and J. D. Gillett. 1965. O’nyong-nyong fever: an
epidemic virus disease in East Africa. VII. Virus isolations from man and
serological studies up to July 1961. Trans. R. Soc. Trop. Med. Hyg. 59:186–197.
VOL. 81, 2007 COMPLEMENT CONTRIBUTES TO RRV-INDUCED DISEASE 5143
